Skip to content
Review Open access

Prostate cancer worldwide: updated epidemiology, disparities, and screening implications.

Oct 2026 · Prostate Cancer and Prostatic Diseases · 0 citations · 69 references
Medicine

TL;DR

Organized, risk-adapted pathways integrating PSA, MRI, biomarkers, and baseline risk may better preserve early-detection benefits while reducing overdiagnosis and inequity.

Abstract

Background

Prostate cancer epidemiology is evolving because of three simultaneous factors: a rising global burden, population aging, and renewed debate about how early detection can reduce advanced disease without returning to non-risk-adapted PSA testing. This Review provides an updated overview of prostate cancer incidence, mortality, prevalence, risk factors, disparities, and screening implications.

Methods

We synthesized recent systematic reviews, meta-analyses, randomized screening trials, and population-based registry data, supplemented by landmark historical studies.

Results

Current trends cannot be interpreted without accounting for screening policy, diagnostic intensity, access to MRI and biomarkers, inherited susceptibility, and health-system capacity. Age, family history, ancestry, and germline risk remain the strongest determinants. Most modifiable exposures are weaker and inconsistent, and are better framed within cardiometabolic health and survivorship care. Organized, risk-adapted pathways integrating PSA, MRI, biomarkers, and baseline risk may better preserve early-detection benefits while reducing overdiagnosis and inequity.

Conclusions

Progress will depend on preventing metastatic disease, minimizing overtreatment, and implementing modern diagnostics equitably.

Read PDF

Similar papers

Review Open access Oct 2026

Early-Onset Colorectal Cancer: Molecular Features, Risk Stratification, Screening Gaps, and Personalized Prevention

Although overall colorectal cancer (CRC) incidence and mortality have declined with widespread screening, early-onset CRC (EOCRC), defined as diagnosis before age 50, continues to rise. EOCRC partially differs from late-onset CRC (LOCRC) in clinical presentation, molecular features, polyp characteristics, and patterns...

Vanessa Lu, Fiona Xu, G. Graziosi et al. · 0 citations
Review Open access Oct 2026

The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections

Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before age 50, has become an increasing global public health concern. Incidence rates have risen among younger adults in many countries, despite stable or declining rates in older populations. This review examines global EOCRC epidemiology, p...

Kacper Wrzosek, Agata Koba, Pola Bakalczuk et al. · 0 citations
Review Open access Sep 2026

Toward Precision Colorectal Cancer Screening: Integrating Clinical Risk Stratification, Molecular Biomarkers, and Artificial Intelligence

The priority for translation is not maximal technological integration, but selective use of additional information when it provides actionable incremental benefit while preserving the accessibility, effectiveness, and public-health strengths of organized screening.

S. Luncă, S. Morarasu, G. Dimofte · 0 citations
Review Open access Oct 2026

Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management

This review synthesizes current advances in CRC epidemiology, risk factors, signaling biology, clinical presentation, screening, diagnosis, and management across the care continuum, and frames CRC as a systems‐level disease in which genomic instability, epigenetic dysregulation, metabolic remodeling, tumor microenviron...

Kai-Rui Wan, Ke Tang, Ling-Long Wang et al. · 0 citations
Review Oct 2026

Risk-stratified Prostate Cancer Screening in 2026: Blood- and Urine-based Biomarkers.

How blood and urine tests, alongside genetic risk information, can help identify the men most likely to harbor aggressive prostate cancer-enabling early detection and intervention while avoiding unnecessary biopsies and potential harm in men at low risk is discussed.

J. Stangl-Kremser, S. Salami · 0 citations
Review Oct 2026

Epidemiology, Risk Factors, and Prevention of Prostate Cancer.

CONTEXT There are substantial regional differences in prostate cancer (PCa) epidemiology reflecting differences in risk factors, screening, management, and access to care. OBJECTIVE To assess geographical differences and temporal trends in PCa incidence and mortality and PCa risk factors. EVIDENCE ACQUISITION Estim...

G. Gandaglia, A. Weiner, A. Briganti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.